Literature DB >> 24206092

B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells.

Frank Secreto1, Michelle Manske, Tammy Price-Troska, Steven Ziesmer, Lucy S Hodge, Stephen M Ansell, James R Cerhan, Anne J Novak.   

Abstract

B-cell activating factor-receptor (BAFF-R) is the primary BAFF receptor that is responsible for promoting B-cell development and survival. Malignant B-cells exploit the BAFF/BAFF-R system, and high serum BAFF levels or genetic alterations in BAFF receptors have been found in B-cell cancers. BAFF signaling impacts pro-survival pathways. However, other than nuclear factor-κB2 (NF-κB2), little is known about the specific pathways activated by individual BAFF receptors. Using a novel BAFF-R expression model we have demonstrated that activation of BAFF-R, independent of transmembrane activator and cytophilin ligand interactor (TACI) and B-cell maturation antigen (BCMA), can induce phosphorylation of Akt and glycogen synthase kinase 3β (GSK3β). Expression of an activated form of BAFF-R also enhanced a pro-survival gene expression pattern, including the novel BAFF-regulated gene Pin1, whose expression was phosphatidyl inositol 3-kinase (PI3K)-dependent. Additionally, we showed that TRAF6 is essential for mediating BAFF-R dependent activation of Akt. Together these data describe a novel role for TRAF6 in BAFF-R-specific activation of the PI3K pathway and provide evidence suggesting a new role for Pin1 in BAFF-R signaling.

Entities:  

Keywords:  BAFF; BAFF-R; PI3K; lymphoma

Mesh:

Substances:

Year:  2014        PMID: 24206092      PMCID: PMC4110115          DOI: 10.3109/10428194.2013.862619

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  63 in total

1.  BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.

Authors:  Javier Briones; John M Timmerman; David M Hilbert; Ronald Levy
Journal:  Exp Hematol       Date:  2002-02       Impact factor: 3.084

2.  TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production.

Authors:  Liang-Guo Xu; Hong-Bing Shu
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

Review 3.  Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.

Authors:  Tae Ho Lee; Lucia Pastorino; Kun Ping Lu
Journal:  Expert Rev Mol Med       Date:  2011-06-20       Impact factor: 5.600

4.  Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.

Authors:  Anne J Novak; Jaime R Darce; Bonnie K Arendt; Brandon Harder; Kathy Henderson; Wayne Kindsvogel; Jane A Gross; Philip R Greipp; Diane F Jelinek
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

5.  BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

Authors:  Estefania Claudio; Keith Brown; Sun Park; Hongshan Wang; Ulrich Siebenlist
Journal:  Nat Immunol       Date:  2002-09-23       Impact factor: 25.606

6.  B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Authors:  Svetlana Shulga-Morskaya; Max Dobles; Meghan E Walsh; Lai Guan Ng; Fabienne MacKay; Sambasiva P Rao; Susan L Kalled; Martin L Scott
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

7.  Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival.

Authors:  Sara Maia; Marc Pelletier; Jixin Ding; Yen-Ming Hsu; Stephen E Sallan; Sambasiva P Rao; Lee M Nadler; Angelo A Cardoso
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

8.  TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Authors:  X Z Xia; J Treanor; G Senaldi; S D Khare; T Boone; M Kelley; L E Theill; A Colombero; I Solovyev; F Lee; S McCabe; R Elliott; K Miner; N Hawkins; J Guo; M Stolina; G Yu; J Wang; J Delaney; S Y Meng; W J Boyle; H Hsu
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

9.  Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

Authors:  H Häcker; R M Vabulas; O Takeuchi; K Hoshino; S Akira; H Wagner
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Phosphoinositide 3-kinase/AKT/mTORC1/2 signaling determines sensitivity of Burkitt's lymphoma cells to BH3 mimetics.

Authors:  Lindsay C Spender; Gareth J Inman
Journal:  Mol Cancer Res       Date:  2012-01-12       Impact factor: 5.852

View more
  3 in total

1.  TRAF6 is required for BLyS-mediated NF-κB signaling in multiple myeloma cells.

Authors:  Xinfeng Wang; Jingjing Wang; Hong Liu; Ruirong Xu; Runsheng Ding; Shenhua Jiang; Xudong Wang; Hongming Huang
Journal:  Med Oncol       Date:  2015-09-03       Impact factor: 3.064

2.  BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R.

Authors:  Nuoyan Zheng; Donxian Wang; Hongyan Ming; Haiqing Zhang; Xueqing Yu
Journal:  BMC Nephrol       Date:  2015-05-15       Impact factor: 2.388

3.  BAFF signaling drives interstitial transformation of mouse renal tubular epithelial cells in a Pin1-dependent manner.

Authors:  Haiyan Xu; Dan Song; Renfang Xu; Xiaozhou He
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-06-14       Impact factor: 2.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.